Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats

Journal of Psychopharmacology

Volumn 22, Issue 5, 2008, Pages 567-571

  Snigdha, Shikha ^a   Thumbi, C ^a   Reynolds, G P ^b   Neill, J C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antipsychotics; Aripiprazole; Hyperphagia; Olanzapine; Rats; Ziprasidone

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE; THIAZOLE DERIVATIVE; ZIPRASIDONE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; EATING; FEMALE; HYPERPHAGIA; MOTOR ACTIVITY; RAT; WEIGHT GAIN;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; EATING; FEMALE; HYPERPHAGIA; MOTOR ACTIVITY; PIPERAZINES; QUINOLONES; RATS; THIAZOLES; WEIGHT GAIN;

EID: 58149202421     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107081519     Document Type: Article

References (32)

1. Allison D B, Menore J L, Heo M, Chandler L P, Cappelleri J C, Infante M C, Weiden P J (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686-1696 (Pubitemid 29517559)
2. Ananth J, Venkatesh R, Burgoyne K, Gadasalli R, Binford R, Gunatilake S (2004) Atypical antipsychotic induced weight gain: pathophysiology and management. Ann Clin Psychiatry 16: 75-85 (Pubitemid 39070973)
3. Baptista T, Parada M, Hernandez L (1987) Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved? Pharmacol Biochem Behav 27: 399-405 (Pubitemid 17107006)
4. Baptista T, La cruz A, Meza T, Contreras Q, Del gado C, Mejìas M A, Hernàndez L (2001) Antipsychotic drugs and obesity: is prolactin involved Can J Psychiatry 46: 829-834
5. Daniels A J, Grizzle M K, Strole C, Ignar D, Jones D N C (2003) Antipsychotic induced weight gain: effects of olanzapine and ziprasidone in female rats. J Psychopharmacol 17: A52
6. Ellingrod V L, Perry P J, Ringold J C, Lund B C, Bever-Stille K, Fleming F, Holman T L, Miller D (2005) Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet B Neuropsychiatr Genet 134: 76-78 (Pubitemid 40411114)
7. Fell M (2006) PhD thesis. Bradford: University of Bradford.
8. Fell M, Marshall K, Williams J, Neill J C (2004a) Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats. J Psychopharmacol 18: 149-155 (Pubitemid 38954901)
9. Fell M, Neill J C, Marshall J (2004b) Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrus cycle and uterine weight in female rats. Eur Neuropsychopharmacol 14: 385-392 (Pubitemid 39141681)
10. Fell M J, Gibson R, McDermott E, Sisodia G, Marshall K M, Neill J C (2005) Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats. Behav Brain Res 160: 338-343 (Pubitemid 40603530)
11. Ganguli R, Brar J S, Ayrton Z (2001) Weight gain over 4months in schizophrenia patients: a comparison of olanzapine and risperidone Schizophr Res 49: 261-267 (Pubitemid 32453227)
12. Gilbert F, Dourish C T, Brazell C, McClue S, Stahl S M (1988) Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats. Psychoneuroendocrinology 13: 471-478 (Pubitemid 19059359)
13. Gothelf D, Falk B, Singer P, Kairi M, Phillip M, Zigel L, Poraz I, Frishman S, Constantini N, Zalsman G, Weizman A, Apter A (2002) Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 159: 1055-1057 (Pubitemid 34586957)
14. Goudie A J, Smith J A, Halford J C (2002) Characterization of olanzapine-induced weight gain in rats. J Psychopharmacol 16: 291-296 (Pubitemid 35470572)
15. Green A I, Lieberman J A, Hamer R M, Glick I D, Gur R E, Kahn R S, McEvoy J P, Perkins D O, Rothschild A J, Sharma T, Tohen M F, Woolson S, Zipursky R B, The HGDH Study Group (2006) Olanzapine and haloperidol in first episode psychosis: Two-year data. Schizophr Res 86: 234-243 (Pubitemid 44251272)
16. Haddad P (2005) Weight change with atypical antipsychotics in the treatment of schizophrenia J Psychopharmacol 19: 16-27
17. Kalinichev M, Rourke C, Daniels A J, Grizzle M K, Britt C S, Ignar D M, Jones D N (2005) Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. Psychopharmacology 182: 220-231 (Pubitemid 41464615)
18. Kirk S, Neill J C, Jones D N, Reynolds G P (2004) Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat. Eur J Pharmacol 505: 253-254 (Pubitemid 39535699)
19. Kroeze W K, Hufeisen S J, Popadak B A, Renock S M, Steinberg S, Ernsberger P, Jayathilake K, Meltzer H Y, Roth B L (2003) H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28: 519-526
20. Leander J, Gleason S (2001) Preclinical studies of weight gain during olanzapine treatment. World J Biol Psychiatry 2(1): 010-003
21. Lin S K, Chen C K (2006) Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, and Dyslipidemia by Aripiprazole: A case report. J Clin Psychiatry 67: 1307
22. McQuade R D, Stock E, Marcus R, Jody D, Gharbia N A, Vanveggel S, Archibald D, Carson W H (2004) A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. J Clin Psychiatry 65: 47-56
23. Minet-Ringuet J, Even P C, Lacroix M, Tome D, de Beaurepaire (2006) A model for antipsychotic-induced obesity in the male rat. Psychopharmacology 187: 447-454 (Pubitemid 44200516)
24. Nasrallah H (2003) A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 28: 83-96
25. National Institute of Clinical Excellence (2002) Health Technology Appraisal No. 43. The clinical effectiveness and cost effectiveness of newer atypical antipsychotic drugs for schizophrenia. NICE, London
26. Neill J C, Cooper S J (1988) MDL 72832, a selective 5-HT1A receptor ligand, sterospecifically increases food intake. Eur J Pharamacology 151: 329-332
27. Neill J C, Cooper S J (1989) Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology (Berl) 97: 213-218 (Pubitemid 19040164)
28. Perkins D O (2002) Predictors of non-compliance in patients with schizophrenia. J Clin Psychiatry 63: 1121-1128
29. Pouzet B, Mow T, Kreilgard M, Kreilgard M, Velschow S (2003) Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human. Pharmacol Biochem Behav 75: 133-140 (Pubitemid 36577588)
30. Reynolds G P (2004) Receptor mechanisms in the treatment of schizophrenia. J Psychopharmacol 18: 340-345
31. Theisen F M, Linden A, Konig I R, Martin M, Remschmidt H, Hebebrand J (2003) Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 110: 111-121 (Pubitemid 36135558)
32. Thornton-Jones Z, Neill J C, Reynolds G P (2002) The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study. J Psychopharmacol 16: 35-37 (Pubitemid 34273071)